最後更新 2024-09-20 08:28:51 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

4.2%


截至2024-06-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

博士倫公司(Bausch + Lomb Corporation)在全球範圍內運營眼健康業務。它通過三個業務部門運營:視力護理/消費者健康護理、眼科藥品和外科手術。

視力護理/消費者健康護理部門提供涵蓋各種佩戴模式的隱形眼鏡,包括即棄式和經常更換的隱形眼鏡;以及隱形眼鏡護理產品、非處方眼藥水、眼部維生素和礦物質補充劑,用於治療各種眼部疾病,如眼部過敏、結膜炎和乾眼症。

眼科藥品部門提供專有和普通處方藥產品,用於術後治療,以及治療青光眼、眼高壓和視網膜疾病等眼部疾病;並提供用於治療用途的隱形眼鏡。

外科手術部門提供治療白內障、玻璃體和視網膜眼部疾病的工具和技術;以及人工晶體和輸送系統、超聲乳化設備,以及其他外科儀器和設備。

該公司成立於1853年,總部位於加拿大的沃恩。



Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning